SCHEMBL2033197

SCHEMBL2033197

[CH2]C1CC(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL428436 0.96
SCHEMBL8319493 0.75
SCHEMBL910899 0.74
SCHEMBL599341 0.71
SCHEMBL598322 0.71
SCHEMBL23420992 0.71
SCHEMBL11810630 0.71 EPHX2 (0.32)
SCHEMBL428437 0.71
SCHEMBL282937 0.71
SCHEMBL425257 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111868055-B Inhibitors of TRPC6 勃林格殷格翰国际有限公司 2024-03-08 CN claimed
EP-4273147-A1 SUBSTITUTED SPIROLACTAMS, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2023-11-08 EP claimed
EP-3328379-B1 BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION UCB Biopharma SRL (BE) 2021-07-28 EP claimed
EP-3752503-A1 INHIBITORS OF TRPC6 Boehringer Ingelheim International GmbH (DE) 2020-12-23 EP claimed
CN-111868055-A Inhibitors of TRPC6 勃林格殷格翰国际有限公司 2020-10-30 CN claimed
WO-2019161010-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-08-22 WO claimed
US-20180222899-A1 BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION NEUROPORE THERAPIES, INC. (US) 2018-08-09 US claimed
EP-3328379-A1 BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION UCB Biopharma SPRL (BE) 2018-06-06 EP claimed
WO-2017020010-A1 BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION NEUROPORE THERAPIES, INC. (US) 2017-02-02 WO claimed
CN-118226708-A Colored curable resin composition, color filter, display device, and solid-state imaging element 住友化学株式会社 2024-06-21 CN disclosed
US-11981670-B2 Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof DYNAVAX TECHNOLOGIES CORPORATION (US) 2024-05-14 US disclosed
CN-117916665-A Colored curable resin composition, color filter, display device, and solid-state imaging element 住友化学株式会社 2024-04-19 CN disclosed
CN-111868055-B Inhibitors of TRPC6 勃林格殷格翰国际有限公司 2024-03-08 CN disclosed
EP-4273147-A1 SUBSTITUTED SPIROLACTAMS, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2023-11-08 EP disclosed
US-5712274-A ANTIINFLAMMATORY, ANTIALLERGEN YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-01-27 US disclosed
EP-0661284-A1 THIENODIAZEPINE COMPOUND AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1995-07-05 EP disclosed
EP-0042513-B1 DIHYDROPYRIDAZINONES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS BASF Aktiengesellschaft (DE) 1984-08-08 EP disclosed
US-4415571-A HYPOTENSIVE AGENTS; THROMBOSIS; ANTICOAGULANTS; CARDIOVASCULAR DISORDDERS BASF AKTIENGESELLSCHAFT (DE) 1983-11-15 US disclosed
EP-0042513-A1 Dihydropyridazinones, processes for their preparation and pharmaceutical compositions containing these compounds BASF Aktiengesellschaft (DE) 1981-12-30 EP disclosed
US-4273725-A Process for preparing chlorothiolformates PPG INDUSTRIES, INC. (US) 1981-06-16 US disclosed